Is Celldex Therapeutics (CLDX) Stock the Next Clovis Oncology (CLVS)?

Will Celldex Therapeutics succeed with Glembatumab vedotin at treating triple negative breast cancer patients to make CLDX stock the next CLVS stock?

Posted in Biotech Hunter, Healthcare & Biotech, Members | Tagged , , , | 1 Comment